FIELD: medicine, pharmacy. SUBSTANCE: invention relates to aerosol compositions used for administration of drugs by inhalation. Pharmaceutical aerosol composition has the ground drug taken from a group consisting of salmeterol, salbutamol, fluticazone-propionate, beclometasone-dipropionate and their pharmaceutically acceptable salts and solvates and fluorohydrocarbon or hydrogen-containing chlorofluorohydrocarbon propellent. Preparation does not contain surface-active substance. Method of treatment of patients with respiratory diseases involves administration of effective amount of a pharmaceutical aerosol preparation by inhalation. Pharmaceutical preparation is a stable dispersion that is effective for treatment of patients with acute or chronic symptoms of disease. EFFECT: improved method of treatment, enhanced effectiveness of a composition. 25 cl, 26 ex
